Clinical Report: Patterns of Weight Change Following Cessation of Medications

Overview

This report summarizes the findings of a correction regarding weight regain trends following the discontinuation of anti-obesity medications. The analysis confirms a consistent pattern of weight regain across multiple studies, emphasizing the importance of ongoing treatment to maintain weight loss.

Background

Understanding weight change patterns after stopping anti-obesity medications is crucial for managing obesity effectively. Weight regain can lead to the reemergence of cardiometabolic risk factors, making it essential for healthcare providers to consider long-term treatment strategies. This topic is particularly relevant given the rising prevalence of obesity and its associated health complications.

Data Highlights

No numerical data presented in the article.

Key Findings

• A general trend of weight regain was confirmed following the cessation of anti-obesity medications.
• Multilevel modeling indicated a progressive increase in body weight after drug discontinuation.
• Exclusion of two studies in sensitivity analysis did not affect the stability of the pooled effect estimate.
• No significant difference in weight regain was found between placebo-controlled and active-controlled trials.
• Data transparency was maintained by using summary data from published studies.

Clinical Implications

Healthcare professionals should be aware that discontinuing anti-obesity medications often leads to weight regain and potential health risks. Continuous pharmacotherapy may be necessary to sustain weight loss and mitigate the risk of cardiometabolic disorders. Clinicians should discuss long-term treatment options with patients to enhance adherence and outcomes.

Conclusion

The findings reinforce the need for ongoing management of obesity through pharmacotherapy to prevent weight regain after cessation of treatment. This underscores the importance of comprehensive care strategies in obesity management.

References

1. The Journal of Clinical Endocrinology & Metabolism, 2023 -- The Influence of Weight Patterns on the Risk of Ten Different Cardiometabolic Disorders
2. Obesity Surgery, 2024 -- Prompt Resumption of Pharmacological Treatment for Obesity in Adolescents Following Laparoscopic Sleeve Gastrectomy: A Retrospective Cohort Analysis
3. The New Gastroenterologist, 2025 -- Strategies for Managing Weight in Gastroenterology Practice
4. The Journal of Clinical Endocrinology & Metabolism, 2023 -- Should Obesity Classification Shift from Body Mass Index to Body Composition Metrics?
5. American Diabetes Association, 2026 -- Standards of Care
6. BMJ, 2026 -- Weight regain after cessation of medication for weight management
7. JAMA, 2023 -- Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial
8. https://ada.silverchair-cdn.com/ada/content_public/journal/care/issue/49/supplement_1/6/standards-of-care-2026.pdf
9. https://waltersport.com/wp-content/uploads/2026/01/Weight-regain-after-cessation-of-medication-for-weight-management-West-et-al.-2026.pdf
10. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial | Clinical Pharmacy and Pharmacology | JAMA | JAMA Network